Janux Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
29.67
|
|
Average Rating
|
4.80
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.49
|
0.00
|
0.49
|
100.00%
|
|
2022-12-31
|
-0.49
|
0.00
|
0.49
|
100.00%
|
|
2022-09-30
|
-0.49
|
-0.40
|
0.09
|
18.37%
|
|
2022-06-30
|
-0.37
|
-0.41
|
-0.04
|
-10.81%
|
|
2022-03-31
|
-0.37
|
-0.32
|
0.05
|
13.51%
|
|
2021-12-31
|
-0.31
|
-0.33
|
-0.02
|
-6.45%
|
|
2021-09-30
|
-0.18
|
-0.26
|
-0.08
|
-44.44%
|
|
2021-06-30
|
-0.13
|
-0.62
|
-0.49
|
-376.92%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.13
|
|
2021-12-31
|
-3.23
|
|
2020-12-31
|
-2.63
|
|
2019-12-31
|
-2.20
|